2024

1. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

   Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555